Shah Preetam (CIK 0001787403)

Latest company ownership

Shares held
217,500
Last filed at
Mar 20, 2024
Confidence Score
50.0
2025Q4
Confidence Score History
2021Q4 2025Q4
Shares held
11,600
Last filed at
Dec 31, 2020
Confidence Score
50.0
2025Q4
Confidence Score History
2019Q4 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Mar 11, 2024 Mar 12, 2024 Cidara Therapeutics, Inc. CFO Sell 46.3 -18,931 -7.69% ✗ $12.7K
Mar 13, 2023 Mar 13, 2023 Cidara Therapeutics, Inc. CFO Sell 46.3 -6,648 -4.29% ✗ $10.2K
Sep 15, 2022 Sep 19, 2022 Cidara Therapeutics, Inc. CFO Sell 46.3 -15,642 -9.40% ✗ $12K
Mar 31, 2022 Apr 4, 2022 Cidara Therapeutics, Inc. CFO Sell 91.3 +92,431 462.16% ✗ $20.6K
Nov 12, 2021 Nov 15, 2021 Cidara Therapeutics, Inc. CFO Buy 91.3 +20,000 100.00% ✗ $30.8K
Dec 30, 2020 Dec 31, 2020 BRAINSTORM CELL THERAPEUTICS INC. CFO Sell 42.5 -25,000 -68.31% ✗ $116K
Dec 24, 2019 Dec 27, 2019 BRAINSTORM CELL THERAPEUTICS INC. CFO Buy 91.3 +11,600 46.40% ✗ $45.9K